By which routes can filgrastim be administered to patients receiving established cytotoxic chemotherapy?

For patients receiving established cytotoxic chemotherapy, filgrastim may be administered by daily subcutaneous injection, preferred in most cases, or daily intravenous infusion diluted in 5% glucose over 30 minutes, with route selection depending on individual clinical circumstances.